Clinical Trial Update: Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the safety and effectiveness of GDC-0032 in combination with tamoxifen for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GDC-0032 (taselisib)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED